Induction of Neutralizing Antibodies against Four Serotypes of Dengue Viruses by MixBiEDIII, a Tetravalent Dengue Vaccine
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Induction of Neutralizing Antibodies against Four Serotypes of Dengue Viruses by MixBiEDIII, a Tetravalent Dengue Vaccine
Authors
Keywords
Antibodies, Enzyme-linked immunoassays, Mouse models, Vaccines, Recombinant proteins, Monoclonal antibodies, Dengue virus, Vaccine development
Journal
PLoS One
Volume 9, Issue 1, Pages e86573
Publisher
Public Library of Science (PLoS)
Online
2014-01-22
DOI
10.1371/journal.pone.0086573
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A consensus envelope protein domain III can induce neutralizing antibody responses against serotype 2 of dengue virus in non-human primates
- (2013) Hsin-Wei Chen et al. ARCHIVES OF VIROLOGY
- A Single Dose of Any of Four Different Live Attenuated Tetravalent Dengue Vaccines Is Safe and Immunogenic in Flavivirus-naive Adults: A Randomized, Double-blind Clinical Trial
- (2013) Anna P. Durbin et al. JOURNAL OF INFECTIOUS DISEASES
- An Alphavirus Vector-Based Tetravalent Dengue Vaccine Induces a Rapid and Protective Immune Response in Macaques That Differs Qualitatively from Immunity Induced by Live Virus Infection
- (2013) L. J. White et al. JOURNAL OF VIROLOGY
- Dengue vaccine efficacy trial: does interference cause failure?
- (2013) Sathyamangalam Swaminathan et al. LANCET INFECTIOUS DISEASES
- The Synergistic Effect of Combined Immunization with a DNA Vaccine and Chimeric Yellow Fever/Dengue Virus Leads to Strong Protection against Dengue
- (2013) Adriana S. Azevedo et al. PLoS One
- Expression and purification of an immunogenic dengue virus epitope using a synthetic consensus sequence of envelope domain III and Saccharomyces cerevisiae
- (2013) Ngoc-Luong Nguyen et al. PROTEIN EXPRESSION AND PURIFICATION
- Targeting of envelope domain III protein of DENV type 2 to DEC-205 receptor elicits neutralizing antibodies in mice
- (2013) Nancy Coconi-Linares et al. VACCINE
- Vaccination of volunteers with low-dose, live-attenuated, dengue viruses leads to serotype-specific immunologic and virologic profiles
- (2013) Janet C. Lindow et al. VACCINE
- A novel platform for virus-like particle-display of flaviviral envelope domain III: induction of Dengue and West Nile virus neutralizing antibodies
- (2013) Anthony JS Chua et al. Virology Journal
- Challenges in the clinical development of a dengue vaccine
- (2013) Derek Wallace et al. Current Opinion in Virology
- Role of Humoral versus Cellular Responses Induced by a Protective Dengue Vaccine Candidate
- (2013) Raphaël M. Zellweger et al. PLoS Pathogens
- Purified and highly aggregated chimeric protein DIIIC-2 induces a functional immune response in mice against dengue 2 virus
- (2012) Ernesto Marcos et al. ARCHIVES OF VIROLOGY
- Eliciting cross-neutralizing antibodies in mice challenged with a dengue virus envelope domain III expressed in Escherichia coli
- (2012) Jie Yang et al. CANADIAN JOURNAL OF MICROBIOLOGY
- Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
- (2012) Arunee Sabchareon et al. LANCET
- Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: Their immunity and protective efficacy in mice
- (2012) Hui Lu et al. MOLECULAR IMMUNOLOGY
- Defeating dengue: a challenge for a vaccine
- (2012) NATURE MEDICINE
- Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions
- (2012) R. de Alwis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice
- (2012) Upasana Arora et al. VACCINE
- Immune Response to Dengue Virus and Prospects for a Vaccine
- (2011) Brian R. Murphy et al. Annual Review of Immunology
- Dengue vaccines: progress and challenges
- (2011) Beth-Ann G Coller et al. CURRENT OPINION IN IMMUNOLOGY
- Cross protection against lethal West Nile virus challenge in mice immunized with recombinant E protein domain III of Japanese encephalitis virus
- (2011) Shi-Hua Li et al. IMMUNOLOGY LETTERS
- A Broadly Flavivirus Cross-Neutralizing Monoclonal Antibody that Recognizes a Novel Epitope within the Fusion Loop of E Protein
- (2011) Yong-Qiang Deng et al. PLoS One
- Immunogenicity and protective efficacy of a vaxfectin-adjuvanted tetravalent dengue DNA vaccine
- (2011) Kevin R. Porter et al. VACCINE
- Review of dengue virus and the development of a vaccine
- (2010) Sarah Murrell et al. BIOTECHNOLOGY ADVANCES
- The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity
- (2010) Martina Beltramello et al. Cell Host & Microbe
- Domain III of the envelope protein as a dengue vaccine target
- (2010) Maria G Guzman et al. Expert Review of Vaccines
- Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
- (2010) W. Dejnirattisai et al. SCIENCE
- A tetravalent recombinant dengue domain III protein vaccine stimulates neutralizing and enhancing antibodies in mice
- (2010) Olivia K.T. Block et al. VACCINE
- Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeys
- (2010) David E. Clements et al. VACCINE
- Evaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trial
- (2010) Charmagne G. Beckett et al. VACCINE
- The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1
- (2010) Bimmi Shrestha et al. PLoS Pathogens
- Lethal Antibody Enhancement of Dengue Disease in Mice Is Prevented by Fc Modification
- (2010) Scott J. Balsitis et al. PLoS Pathogens
- Progress towards a dengue vaccine
- (2009) Daniel P Webster et al. LANCET INFECTIOUS DISEASES
- The Cellular Immune Response Plays an Important Role in Protecting Against Dengue Virus in the Mouse Encephalitis Model
- (2009) Lázaro Gil et al. VIRAL IMMUNOLOGY
- Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody
- (2009) W.M.P.B. Wahala et al. VIROLOGY
- Mouse models of dengue virus infection and disease
- (2008) L YAUCH et al. ANTIVIRAL RESEARCH
- Dengue-4 envelope domain III fused twice within the meningococcal P64k protein carrier induces partial protection in mice
- (2008) Laura Lazo et al. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
- Characterization of Dengue Virus Complex-Specific Neutralizing Epitopes on Envelope Protein Domain III of Dengue 2 Virus
- (2008) G. D. Gromowski et al. JOURNAL OF VIROLOGY
- A novel dengue vaccine candidate that induces cross-neutralizing antibodies and memory immunity
- (2008) Chih-Hsiang Leng et al. MICROBES AND INFECTION
- Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins
- (2008) Shee-Mei Lok et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Immunogenicity of a recombinant envelope domain III protein of dengue virus type-4 with various adjuvants in mice
- (2008) J. Pradeep Babu et al. VACCINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now